本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Benitec Biopharma Limited

11.33
-0.7500-6.21%
成交量:16.08萬
成交額:183.73萬
市值:3.88億
市盈率:-12.13
高:12.12
開:12.11
低:11.08
收:12.08
52周最高:16.76
52周最低:9.85
股本:3,425.49萬
流通股本:1,792.50萬
量比:2.23
換手率:0.90%
股息:- -
股息率:- -
每股收益(TTM):-0.9338
每股收益(LYR):-1.0472
淨資產收益率:-29.58%
總資產收益率:-19.93%
市淨率:2.12
市盈率(LYR):-10.82

資料載入中...

2020/02/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/12

SEC問詢函

[Cover]Correspondence
2019/12/09

招股説明書

Registration statement for certain foreign private issuers
2019/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/30

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/10/08

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/10/07

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/09/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]